Patricia Andrews has been appointed CEO of Boston Biomedical. Andrews will succeed Chiang Li, who has led the company since he founded the Cambridge, MA-based cancer drug developer in 2007. Andrews came to Boston Biomedical in 2013 from Wilmington, DE-based Incyte (NASDAQ: [[ticker:INCY]]), where she was chief commercial officer. Boston Biomedical promoted her to chief operating officer in 2015. She starts as CEO on April 24.
Author: Frank Vinluan
Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.
View all posts by Frank Vinluan
